EMR analyst estimates
Emerson (EMR) analyst ratings, the average price target and its range, and every firm's latest call.
EMR analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Oct 15, 2026 | Mizuho Securities | Emerson price target raised to $180 from $173 at Mizuho | $180.00 |
| Sep 24, 2026 | Wells Fargo | Emerson initiated with an Overweight at Wells Fargo | $177.00 |
| Aug 28, 2026 | Morgan Stanley | Emerson price target raised to $135 from $125 at Morgan Stanley | $135.00 |
| Aug 24, 2026 | D.A. Davidson | Emerson price target raised to $155 from $145 at DA Davidson | $155.00 |
| Aug 14, 2026 | Bernstein | Emerson price target raised to $186 from $169 at Bernstein | $186.00 |
| Aug 7, 2026 | BMO Capital | Emerson price target raised to $175 from $150 at BMO Capital | $175.00 |
| Aug 5, 2026 | RBC Capital | Emerson price target raised to $179 from $169 at RBC Capital | $179.00 |
| Aug 5, 2026 | Robert W. Baird | Emerson price target raised to $171 from $160 at Baird | $171.00 |
| Jul 20, 2026 | Bernstein | Emerson (EMR) PT Lowered to $169 at Bernstein SocGen GroupMember Login | $169.00 |
| Jul 13, 2026 | KeyBanc | Emerson price target lowered to $170 from $185 at KeyBanc | $170.00 |
| Jul 9, 2026 | Wolfe Research | Emerson price target lowered to $167 from $171 at Wolfe Research | $167.00 |
| Jun 15, 2026 | D.A. Davidson | Emerson initiated with a Neutral at DA Davidson | $145.00 |
| Jun 9, 2026 | Bernstein | Emerson initiated with an Outperform at Bernstein | $175.00 |
| May 6, 2026 | Barclays | Emerson price target raised to $144 from $140 at Barclays | $144.00 |
| May 6, 2026 | RBC Capital | Emerson price target raised to $169 from $161 at RBC Capital | $169.00 |
- 17 firms rate EMR: 8 buy, 8 hold, 1 sell.
- The average price target is $167.18 from 11 analysts, from $135.00 to $186.00.
Updated 2026-11-02 17:51 UTC